Mathilde Cabart
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- PARP inhibition in cancer therapy 2
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Guilhem Roubaud (6 shared papers)Diego Teyssonneau (2 shared papers)Nicolas Sévenet (1 shared paper)Henri Margot (1 shared paper)Isabelle Soubeyran (1 shared paper)Paul Sargos (1 shared paper)Sophie Cousin (5 shared papers)François Chomy (5 shared papers)
- Journals
- Annals of Oncology (5 papers)Clinical Cancer Research (2 papers)Journal of Geriatric Oncology (2 papers)Clinical Colorectal Cancer (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Mathilde Cabart
21 papers receiving 876 citations
Mathilde Cabart's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 513
- Pulmonary and Respiratory Medicine 188
- Immunology 99
- Cancer Research 53
- Biological Psychiatry 3
Countries citing papers authored by Mathilde Cabart
This map shows the geographic impact of Mathilde Cabart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Cabart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Cabart more than expected).
Fields of papers citing papers by Mathilde Cabart
This network shows the impact of papers produced by Mathilde Cabart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Cabart. The network helps show where Mathilde Cabart may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathilde Cabart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression Hit paper breakdown → | 2021 | 464 |
| 2 | 2021 | 112 | |
| 3 | 2022 | 59 | |
| 4 | 2023 | 43 | |
| 5 | 2022 | 38 | |
| 6 | 2024 | 26 | |
| 7 | PFMG2025–integrating genomic medicine into the national healthcare system in France Hit paper breakdown → | 2025 | 26 |
| 8 | 2017 | 19 | |
| 9 | 2019 | 18 | |
| 10 | 2021 | 16 | |
| 11 | 2023 | 16 | |
| 12 | 2022 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2016 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2016 | 5 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2023 | 1 |
About Mathilde Cabart
Mathilde Cabart is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology, Surgery and Public Health, Environmental and Occupational Health, having authored 22 papers that have together received 891 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Telemedicine and Telehealth Implementation (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), PARP inhibition in cancer therapy (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Urinary and Genital Oncology Studies (1 paper). The work is most often cited by research in Oncology (513 citations), Pulmonary and Respiratory Medicine (188 citations), Immunology (99 citations), Cancer Research (53 citations) and Biological Psychiatry (3 citations). Mathilde Cabart has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Guilhem Roubaud, Diego Teyssonneau, Nicolas Sévenet, Henri Margot, Isabelle Soubeyran, Paul Sargos, Sophie Cousin, François Chomy, Antoîne Italiano and Alban Bessede. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Journal of Geriatric Oncology, Clinical Colorectal Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.